Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results

Provided By Globe Newswire

Last update: Feb 16, 2022

RARITAN, N.J., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the fourth quarter and fiscal year ended January 2, 2022.